# First Light Diagnostics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/first-light-diagnostics

- Industry: Medical Devices & Equipment
- Headquarters: Chelmsford, US
- Website: www.firstlightdx.com
- Total disclosed funding: $8.3M
- Latest round: Series A (Jan 16, 2019)
- Investors on record: 7

## About

Founded in 2006 and based in Massachusetts, US, First Light Biosciences, Inc. develops diagnostic devices for the detection of pathogens that can cause life-threatening infections. They develop the MultiPath™ Analyzer platform which can perform various tests at the same time. The tests the can be performed using the platform are pathogen identification, toxin and biomarker detection, and rapid phenotypic antimicrobial susceptibility testing.

## Funding rounds

- Series A, Jan 16, 2019, $8.3M — LRVHealth, Life Science Angels, Inc., Beacon Angels, Think.Health Ventures, The 10x Group
- Series A, Sep 16, 2015 — Keiretsu Forum, Life Science Angels, Inc., Keiretsu Capital

## Investors

- Keiretsu Forum — Series A
- Life Science Angels, Inc. — Series A
- Keiretsu Capital (https://capitalatlas.ai/funds/keiretsu-capital) — Series A
- LRVHealth (https://capitalatlas.ai/funds/lrvhealth) — Series A
- Beacon Angels (https://capitalatlas.ai/funds/beacon-angels) — Series A
- Think.Health Ventures (https://capitalatlas.ai/funds/think-health-ventures) — Series A
- The 10x Group (https://capitalatlas.ai/funds/the-10x-group) — Series A